CTMX Stock AI Analysis
CytomX Therapeutics Inc
- Overview
- Stock Analysis
- Trading Parameters
- Hold Track RecordNEW
- Scores Evolution
- Company Profile
- 1M
- 3M
- 6M
- 1Y
- 5Y
- All
Custom range→
Custom range→
CTMX AI-Powered Stock Analysis
AI Score Explanation
Generating AI Score explanation
We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.AI Score Alpha Factors
These AI Factors group the most impactful alpha signals used by Danelfin's AI to calculate the stock’s probability advantage. Positive factors (green) increase the probability of beating the market, while negative factors (red) reduce it.
- Valuation+1.90%How the stock is priced relative to its fundamentals
- Momentum+1.33%Direction and strength of recent price movements
- Earnings Quality+1.18%Stability and reliability of reported earnings
- Size & Liquidity+0.31%Company size and trading liquidity
- Profitability-1.44%Profitability and operating efficiency metrics
- Volatility-0.55%How much the stock price tends to fluctuate
- Sentiment-0.20%How analysts and the market view the stock
CTMX probability advantage of beating the market (3M):
+2.53%Alpha Signals: What Drives the AI Score
Alpha Signals show the individual signals used by Danelfin's AI to calculate a stock's probability of beating the market over the next 3 months. Each signal highlights its positive or negative impact on the probability advantage and helps explain what is driving the AI Score.
AI Score
Hold
Average probability of any US-listed stock of beating the market (3M)50.82% CTMX probability advantage of beating the market (3M)+2.53% CTMX probability of beating the market (3M)53.35%
CTMX probability advantage of beating the market (3M): +2.53%
Type | Alpha Signal | Current Value | Value Decile Position | Probability Advantage Impact (3M) |
|---|---|---|---|---|
Fundamental | Operating Cash Flow (Qtr Discrete) | -25.55 | +2.09% | |
Fundamental | Fundamentals Impact (Long Tail) | - | N/A | +1.91% |
Fundamental | Gross Margin | 100 | -1.10% | |
Sentiment | Fear & Greed Index (CNN) | 31 | N/A | -1.08% |
Fundamental | Sloan Ratio | 0.56 | -0.91% | |
Sentiment | Industry (GICS) | Biotechnology | N/A | +0.91% |
Technical | Chart Pattern (252d) | figure_13 | N/A | +0.62% |
Technical | Distance from KAMA (20d) | 0.18% | -0.59% | |
Technical | Chart Pattern (504d) | figure_31 | N/A | +0.55% |
Technical | Alpha Last Day | 0.07% | -0.50% | |
Sentiment | +0.48% | |||
Fundamental | -0.47% | |||
Fundamental | +0.46% | |||
Technical | +0.45% | |||
Sentiment | +0.43% |
Significant changes Vs previous day
CTMX Trading Parameters
CTMX Average Past Performance & Win Rate
CTMX Frequently Asked Questions
CytomX Therapeutics Inc Company Profile
Pros
Cons
- CTMX / US23284F1057
- Market Cap$831.62M
- Short Float-
- Volume5.12M
- Dividend %-
- Perf Week+17.43%
- Perf Quarter-15.78%
- Perf Year+62.71%
- Perf YTD-9.85%
- 52W High6.75 -43.11%
- 52W Low1.76 118.18%
- Avg Volume-
- Beta-
- ATR0.22
- Volatility-
CTMX Company Profile Summary
CTMX Related Investment Themes
CTMX Related Stocks
Company | AI Score | Compare |
|---|---|---|
CTMX Top 10 Industry Stocks
Biotechnology
Company | AI Score | Compare | |
|---|---|---|---|
CTMX Top 10 Sector Stocks
Health Care
Company | AI Score | Compare | |
|---|---|---|---|